Christopher John Kenney, Chief Medical Officer: Xenon Pharmaceuticals XENE Planned sale · Filed 03/13

Trade details

Type: Planned sale notice
Stock: Xenon Pharmaceuticals XENE
Person: Christopher John KenneyChief Medical Officer
Planned sale date: 26/03/13
Filed: 26/03/13

More to sell after $166.6K in 3 months

Xenon Pharmaceuticals trades, last 26 weeks

What else happened in Xenon Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 02/11~04/12

Christopher John Kenney's recent trades

Christopher John KenneyChief Medical Officer
Planned sale10b5-1 planXenon Pharmaceuticals
Planned sale10b5-1 plan
Xenon Pharmaceuticals
XENE
$437.7K
7,068 sh
$437.7K
Filed 08/28
Traded 08/28
Christopher John KenneyChief Medical Officer
Sell10b5-1 planXenon Pharmaceuticals
Sell10b5-1 plan
Xenon Pharmaceuticals
XENE
$77.9K
1,410 sh
$77.9K
Filed 03/13
Traded 03/13
Christopher John KenneyChief Medical Officer
Sell10b5-1 planXenon Pharmaceuticals
Sell10b5-1 plan
Xenon Pharmaceuticals
XENE
$166.6K
2,771 sh
$166.6K
Filed 03/11
Traded 03/10
Christopher John KenneyChief Medical Officer
Planned sale10b5-1 planXenon Pharmaceuticals
Planned sale10b5-1 plan
Xenon Pharmaceuticals
XENE
$166.6K
2,771 sh
$166.6K
Filed 03/10
Traded 03/10
Christopher John KenneyChief Medical Officer
SellXenon Pharmaceuticals
Sell
Xenon Pharmaceuticals
XENE
$24.5K
700 sh
$24.5K
Filed 23/03/24
Traded 23/03/24